Leadership
Executive Committee
The Executive Committee leads SAABHL and also serves as the Local Organising Committee for the 2027 World Congress for Medical Law.

Dr Howard Snoyman
Head of Legal and Ethics, Discovery Health Medical Scheme
Howard Snoyman is an admitted attorney and ethicist, and Head of Legal and Ethics at Discovery Health Medical Scheme, South Africa’s largest medical scheme. Alongside legal and ethical matters, his portfolio covers the commercial, governance and risk activities of the business.
He holds an LLB, an MSc Med (Bioethics and Health Law) and a PhD examining how the law would need to change to broaden access to healthcare and healthcare insurance in South Africa. Howard serves on the board of the Marketing Code Authority and on the statutory Committee for Auditor Ethics at the Independent Regulatory Board for Auditors.
He was named in the inaugural Legal 500 General Counsel Powerlist, South Africa (2024), is a Certified Ethics Officer and a Certified Fraud Examiner, and has been a member of the World Association for Medical Law since 2011.

Altair Richards
Executive, Corporate Commercial, ENS
Altair Richards is an Executive in the Corporate Commercial department of Edward Nathan Sonnenbergs (ENS), the largest law firm in Africa. She has specialised in healthcare law and regulatory work for two decades and is recognised as one of South Africa’s leading healthcare law experts.
Her clients have included pharmaceutical manufacturers (innovator, generic and animal health), medical device and complementary medicine manufacturers, retail pharmacy, industry and professional associations, medical schemes, administrators and managed healthcare organisations, and hospitals, as well as food, pet food and food packaging companies.
Altair holds an LLB (cum laude) and a Certificate in Legal Practice, both from the University of South Africa.

Dr Alistair McAlpine
Dentist and general medical practitioner
Dr Alistair McAlpine is dually qualified as a dentist and a general medical practitioner, and has gone on to specialise in aesthetic medicine and hormone replacement therapy.
He lectures regularly at local and international medical congresses and has written numerous peer-reviewed articles. His qualifications include a BDS and an MBBCh.

Neil Kirby
Director and Head of Healthcare Services, Werksmans
Neil Kirby is an admitted attorney and a Director at Werksmans Attorneys, where he heads the firm’s Healthcare Services practice. He is a member of the Board of Governors of the World Association for Medical Law and has attended its congresses since 2004.
He has been named a leading lawyer in Life Sciences – Regulatory by Who’s Who Legal (2015–2021), in Dispute Resolution and Public Law by Chambers Global, and in Dispute Resolution and Healthcare by The Legal 500. Within the International Bar Association he has chaired the Healthcare & Life Sciences Law Committee and the Corporate Social Responsibility Committee, and served on the Council of the Legal Practice Division.
Neil is a contributing author of Healthcare in South Africa, reviews the Medical Schemes title in LexisNexis’ Forms & Precedents, and is co-patron of the South African Cystic Fibrosis Trust. He holds BA, LLB and LLM degrees from the University of the Witwatersrand.

David Geral
Partner, Bowmans
David Geral has been a partner at Bowmans, one of Africa’s pre-eminent law firms, since 2001, and co-convenes its Pharmaceutical and Healthcare sector team. For more than 25 years he has advised the medical schemes regulator, open and restricted schemes, scheme administrators, hospital operators, medical insurers and brokers.
Admitted as an attorney and notary public, David is also an accredited commercial mediator. He is a leading voice on impact investing, social impact bonds and ESG investing in South Africa: he wrote the South African chapter of A Legal Framework for Impact (2021), has advised the UN Principles for Responsible Investment, and co-authored A Guide to Impact Bond Investing (2016).
He was shortlisted for the TrustLaw World Pro Bono Lawyer of the Year Award in 2018, and holds a BA and an LLB.

Prof Kevin Behrens
Director, Steve Biko Centre for Bioethics, Wits
Prof Kevin Behrens is Professor of Bioethics and Director of the Steve Biko Centre for Bioethics at the University of the Witwatersrand. He lectures locally and internationally on ethics and bioethics and has published widely in peer-reviewed journals.
Kevin is a Board member of the International Association of Bioethics and has been a clinical bioethics consultant to the Lenmed Hospital Group since 2020. He previously served on the Research Ethics Committee of the Council for Scientific and Industrial Research and as Editor-in-Chief of the African Journal of Business Ethics.
His qualifications include a BA, an MA and a DLitt et Phil in practical and applied ethics.

Val Beaumont
Executive Officer, Marketing Code Authority
Val Beaumont is a pharmacist and the Executive Officer of the Marketing Code Authority (MCA), the self-regulatory body set up by South Africa’s pharmaceutical industry to govern and adjudicate on the ethical marketing and promotion of medicines and medical devices.
She is a Fellow of the Pharmaceutical Society of South Africa, a past member of the South African Pharmacy Council and the founder of the accredited healthcare training organisation Health Science Academy. Val is a former Executive Director of Innovative Medicines South Africa (IMSA).
Her qualifications include a BPharm, an MPharm and an MSc Med (Bioethics and Health Law).
